cipla - Latest News, Analysis, Opinion

Cipla Limited, the Indian pharmaceutical major headquartered in Mumbai has reported its earnings for the quarter that ended on 31st March 2023, the Indian pharma giant has registered a rise of 8.3 per cent in its consolidated revenue to be recorded at Rs 5,739 crores in the Quarter Four of Financial Year 2022(Q4FY23) up from Rs 5,260 crores in the corresponding quarter last year

Quarter Four To Be Steady For Healthcare & Pharma: Report

On Thursday equity research firm Kotak Institutional Equities said that healthcare and pharmaceutical sector have a steady quarter in store, the firm expects steady performance for its pharma coverage in Q4FY23, with stable US sales and healthy domestic growth, amid lower cost pressures driving 14 per cent year on year EBITDA growth (ex-BIOS)

Hurting Generic Industry Compelling Pharma To Spend More On R&D

Industry experts contend that largely the research budgets of the top firms have remained flattish in the last two to three years on account of Covid, but the scenario might be changing for some select firms like Sun Pharmaceuticals, Dr Reddy’s Labs, Zydus Lifesciences, Cipla and Biocon Biologics among others due a hurting generic pharma industry

Asthma Plagued By Myths, Stigma, & Lack Of Information: Dr Vikas Gupta

In an interaction with BW Healthcare World, Dr Vikas Gupta, India Business Rx Head, Cipla speaks on the causes of the increasing asthma burden of India, its solutions, stigmas, challenges and awareness and management of the disease

Q2 Results: Cipla Registers 5.7% Rise In Revenue, Reports PAT At Rs 789 Cr

The pharmaceutical company’s net profit also jumped by 10.91 per cent quarter on quarter in Q2FY22, the company recorded a net profit of Rs 788.90 crores in the September quarter

Cipla Betting High On Digitisation, Emerging Segments

Over the past few years, the company has set up several foundational elements to drive the digitisation and automation plans right from adopting latest trends to transform patient reach and customer care via digitalisation, Hamied stated

Cipla Reports Decline In Net Profit To Rs 706 Cr In Q1 Results

Companies & Markets

The Mumbai-based company had reported a net profit of Rs 710 crore in the April-June quarter of the last fiscal

Cipla To Aquire Additional Stake Worth Rs 26 Cr In GoApptiv

Companies & Markets

Cipla's earlier investment in GoApptiv in June 2020 has yielded growth and expanded Cipla's channel

Cipla To Acquire 21% Stake In Diagnostic Company Achira Labs For Rs 25 Cr

Healthcare

The company has signed definitive agreements with Achira Labs for the purpose, Cipla said in a regulatory filing

Cipla's Sales Increase 14% To Rs 52 Bn In Q4FY22

Companies & Markets

EBITDA came in at Rs 9.5 billion while PAT adjusted at Rs 5.9 billion

Cipla To Acquire 32.49% Stake In Solar Power Firm Amp Energy

Energy & Infra

The acquisition is in line with the commitment to enhance the share of renewable power sources in its operation and to comply with regulatory requirements for being a captive user under Indian electricity laws

InvaGen To Continue To Hold Shares In Avenue Therapeutics: Cipla

Health

Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business firm Avenue Therapeutics for up to USD 215 million.

Cipla Unit Gets Notice From US Firm For Termination Of Acquisition Deal